Idiopathic inflammatory myopathies: one year in review 2023.
Journal
Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521
Informations de publication
Date de publication:
Feb 2024
Feb 2024
Historique:
received:
29
01
2024
accepted:
07
02
2024
medline:
18
3
2024
pubmed:
15
3
2024
entrez:
15
3
2024
Statut:
ppublish
Résumé
Idiopathic inflammatory myopathies are a group of rare, autoimmune, diseases typically involving striate muscle and also variously affecting several other systems or organs, such as joints, skin, lungs, heart and gastrointestinal tract. IIM are mainly characterised by subacute onset and chronic course and are burdened by significant morbidity and mortality. Despite the rarity of these conditions, several efforts have been undertaken in the last years to better understand their pathogenesis, as well as to achieve a more precise classification and to define the optimal therapeutic approach. The aim of this review is to provide an up-to-date digest of the most relevant studies published on this topic over the last year.
Identifiants
pubmed: 38488099
pii: 20853
doi: 10.55563/clinexprheumatol/dh5o6c
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM